Publication | Open Access

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

VaccinationPulmonary TuberculosisVaccine DevelopmentVaccine ResearchVaccine TargetTuberculosis PreventionImmunologyClinical TrialsVaccine TestingTuberculosisPreventive TreatmentTuberculosis DiagnosticsMedicinePreclinical Evaluation